title: Hemovigilance program-India.
abstract: A centralized hemovigilance program to assure patient safety and to promote public health has been launched for the first time in India on Dec 10, 2012 in 60 medical colleges in the first phase along with a well-structured program for monitoring adverse reactions associated with blood transfusion and blood product administration. National Institute of Biologicals (NIB) will be the National Coordinating Centre for Hemovigilance. This program will be implemented under overall ambit of Pharmacovigilance Program of India (PvPI), which is being coordinated by Indian Pharmacopoeia Commission (IPC). All medical colleges of the country will be enrolled in this program by the year 2016 in order to have a National Centre of Excellence for Hemovigilance at NIB, which will act as a global knowledge platform.
authors.affiliation: Indian Pharmacopoeia Commission, Ministry of Health and Family Welfare, Government of India, Ghaziabad, India.
authors.forename: Akanksha
authors.initials: A
authors.lastname: Bisht
authors.forename: Surinder
authors.initials: S
authors.lastname: Singh
authors.forename: Neelam
authors.initials: N
authors.lastname: Marwaha
keywords: Hemovigilance; India; Medical colleges; Transfusion Reaction Reporting Form
references.citation: Hematol J. 2004;5 Suppl 3:S74-82
references.pmid: 15190283
references.citation: Transfus Med. 2004 Aug;14(4):257-73
references.pmid: 15285722
references.citation: Asian J Transfus Sci. 2012 Jul;6(2):137-8
references.pmid: 22988376